XERIS BIOPHARMA HOLDINGS INC (XERS) Stock Analyst Earnings Estimates
NASDAQ:XERS - Nasdaq - US98422E1038 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 49.6M 143.14% | 110.2M 122.18% | 163.914M 48.74% | 205.08M 25.11% | 244.64M 19.29% | 291.99M 19.35% | 334.9M 14.70% | 418.95M 25.10% | 415.69M -0.78% | 445.51M 7.17% | |
| EBITDA YoY % growth | -104.62M -27.38% | -59.56M 43.07% | -31.68M 46.81% | -22.287M 29.65% | 6.936M 131.12% | 42.84M 517.65% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -106.5M -27.39% | -71.8M 32.58% | -44.01M 38.70% | -39.375M 10.53% | -7.87M 80.01% | 33.641M 527.48% | 71.148M 111.49% | 122.99M 72.87% | 155.31M 26.28% | 182.48M 17.49% | |
| Operating Margin | -214.72% | -65.15% | -26.85% | -19.20% | -3.22% | 11.52% | 21.24% | 29.36% | 37.36% | 40.96% | |
| EPS YoY % growth | -1.52 33.33% | -0.70 53.95% | -0.45 35.71% | -0.41 8.20% | -0.22 47.33% | 0.06 127.19% | 0.24 305.17% | 0.64 168.09% | 0.96 49.21% | 1.16 21.28% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.06 35.40% | -0.07 51.43% | -0.05 52.40% | -0.03 75.27% | -0.01 78.95% |
| Revenue Q2Q % growth | 59.266M 33.51% | 55.998M 37.80% | 60.418M 25.70% | 64.736M 19.29% | 67.014M 13.07% |
| EBITDA Q2Q % growth | 2.856M 14.74% | 1.836M 116.38% | 1.836M 185.04% | 3.162M 182.19% | 4.488M 57.14% |
| EBIT Q2Q % growth | -3.36M 65.86% | -4.454M 68.73% | -1.938M 76.33% | 1.428M 111.08% | 2.992M 189.05% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.11 -22.22% | -0.09 | -0.02 | -19.83% |
| Q2 2024 Q2Q % growth | -0.10 28.57% | -0.11 | 0.01 | 8.09% |
| Q1 2024 Q2Q % growth | -0.14 -16.67% | -0.12 | -0.02 | -17.64% |
| Q4 2023 Q2Q % growth | -0.10 | -0.10 | 0.00 | -0.04% |
| Q3 2023 Q2Q % growth | -0.09 43.75% | -0.12 | 0.03 | 23.94% |
| Q2 2023 Q2Q % growth | -0.14 26.32% | -0.13 | -0.01 | -7.65% |
| Q1 2023 Q2Q % growth | -0.12 52.00% | -0.17 | 0.05 | 29.76% |
| Q4 2022 Q2Q % growth | -0.10 76.19% | -0.16 | 0.06 | 37.75% |
| Q3 2022 Q2Q % growth | -0.16 58.97% | -0.17 | 0.01 | 4.93% |
| Q2 2022 Q2Q % growth | -0.19 53.66% | -0.23 | 0.04 | 19.01% |
| Q1 2022 Q2Q % growth | -0.25 16.67% | -0.26 | 0.01 | 3.50% |
| Q4 2021 Q2Q % growth | -0.42 -2.44% | -0.25 | -0.17 | -68.76% |
| Q3 2021 Q2Q % growth | -0.39 -11.43% | -0.38 | -0.01 | -3.34% |
| Q2 2021 Q2Q % growth | -0.41 34.92% | -0.31 | -0.10 | -33.99% |
| Q1 2021 Q2Q % growth | -0.30 66.29% | -0.35 | 0.05 | 14.13% |
| Q4 2020 Q2Q % growth | -0.41 66.67% | -0.39 | -0.02 | -5.23% |
| Q3 2020 Q2Q % growth | -0.35 71.31% | -0.53 | 0.18 | 33.76% |
| Q2 2020 Q2Q % growth | -0.63 50.78% | -0.75 | 0.12 | 15.62% |
| Q1 2020 Q2Q % growth | -0.89 16.82% | -0.91 | 0.02 | 1.74% |
| Q4 2019 Q2Q % growth | -1.23 | -1.16 | -0.07 | -6.34% |
| Q3 2019 Q2Q % growth | -1.22 | -1.25 | 0.03 | 2.56% |
| Q2 2019 Q2Q % growth | -1.28 | -0.96 | -0.32 | -33.50% |
| Q1 2019 Q2Q % growth | -1.07 | -0.78 | -0.29 | -38.03% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 54.268M 12.31% | 52.462M | 1.806M | 3.44% |
| Q2 2024 Q2Q % growth | 48.065M 26.46% | 46.727M | 1.338M | 2.86% |
| Q1 2024 Q2Q % growth | 40.638M 22.42% | 42.651M | -2.013M | -4.72% |
| Q4 2023 Q2Q % growth | 44.39M 33.95% | 44.423M | -33K | -0.07% |
| Q3 2023 Q2Q % growth | 48.32M 62.53% | 41.905M | 6.415M | 15.31% |
| Q2 2023 Q2Q % growth | 38.008M 50.17% | 35.534M | 2.474M | 6.96% |
| Q1 2023 Q2Q % growth | 33.196M 50.41% | 31.381M | 1.815M | 5.78% |
| Q4 2022 Q2Q % growth | 33.14M 54.64% | 31.659M | 1.481M | 4.68% |
| Q3 2022 Q2Q % growth | 29.73M 168.81% | 29.705M | 25K | 0.08% |
| Q2 2022 Q2Q % growth | 25.31M 184.06% | 26.042M | -732K | -2.81% |
| Q1 2022 Q2Q % growth | 22.07M 169.15% | 24.059M | -1.989M | -8.27% |
| Q4 2021 Q2Q % growth | 21.43M 198.88% | 19.276M | 2.154M | 11.17% |
| Q3 2021 Q2Q % growth | 11.06M 17.04% | 11.247M | -187K | -1.66% |
| Q2 2021 Q2Q % growth | 8.91M 338.92% | 9.735M | -825K | -8.47% |
| Q1 2021 Q2Q % growth | 8.2M 358.10% | 7.617M | 583K | 7.65% |
| Q4 2020 Q2Q % growth | 7.17M 291.80% | 8.372M | -1.202M | -14.36% |
| Q3 2020 Q2Q % growth | 9.45M 2,948.39% | 4.568M | 4.882M | 106.87% |
| Q2 2020 Q2Q % growth | 2.03M 576.67% | 1.899M | 131K | 6.90% |
| Q1 2020 Q2Q % growth | 1.79M 616.00% | 1.457M | 333K | 22.86% |
| Q4 2019 Q2Q % growth | 1.83M | 670.548K | 1.159M | 172.91% |
| Q3 2019 Q2Q % growth | 310K | 51K | 259K | 507.84% |
| Q2 2019 Q2Q % growth | 300K | 51K | 249K | 488.24% |
| Q1 2019 Q2Q % growth | 250K | 102K | 148K | 145.10% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 9.53% | 17.4% | 0.82% | -1.67% |
| Revenue | 2.4% | 13.64% | 0.38% | 3.96% |